Convey Your Benefits, Optimize Pricing

Pricing and
Benefits

The right pricing of healthcare products is complex both for reimbursement and out-of-pocket offers. We develop your pricing strategy and make sure that you successfully convey your value add.

Explore Our Services Get In Touch

Pricing and Benefit Services

Pricing Strategy

Pricing healthcare products, whether reimbursed by statutory or private health insurances or offered as out-of-pocket options, whether traditional/physical or digital, is a complex task. We develop a pricing strategy that reasonably balances market acceptance and economic interests.

The right pricing strategy for the German healthcare market requires a deep understanding of the involved stakeholders, their motivations, and interests: from health insurances and prescribers to patients themselves. We have extensive expertise in developing pricing strategies for the German market, starting from the regulatory framework to understanding the market’s willingness-to-pay, and crafting your pricing strategy.

Value Dossier Creation

Just having a great healthcare product is often not sufficient: Especially when it comes to reimbursement paths, conveying the economic and healthcare benefits of your product to insurers is critical. We create your value dossier.

Successful value dossiers are much more than a collection of study results. They convey the benefits, the true value add of your product in an understandable, concise, and appealing way: Essentially, the value dossier is the critical pitch for your healthcare product. We develop your value dossiers: Enriching your data on healthcare and economic benefits with our expertise of value dossier creation, your target audience, and a deep understanding of what matters for payers.

Voice of Prescriber

Especially for a reimbursement market access path, prescribers are important gate keepers: Our established Voice-of-Prescriber Studies provide first-hand insights from these critical stakeholders.

The regulatory approval of a pharmaceutical or medtech product is just the beginning. The success of your prescription product in the German market will essentially depend on prescribers or HCPs in general. They need to be aware of your innovation, repositioning, or existing product, understand and approve it, be convinced of its benefits, and prescribe or recommend it to their patients. Medical professionals are one of the most valuable source of feedback to make your product more successful. Voice-of-Prescriber studies are qualitative, highly insightful first-hand studies with relevant prescribers: Where are the pain points in the decision making and prescription process? Which aspects are most important to prescribers? How should I adjust my product to better support HCPs, their processes, and therapies?

Voice of Patient

It is already an established best practice to include patients – or more generally users during product development. But when it comes to market access or go-to-market decisions, the devil is in the details.

Similar to Voice-of-Prescriber studies, Voice-of-Patient studies are one of our most powerful, insightful, and most frequently used tools to support our clients with real-world market-access and go-to-market decisions. In-person qualitative patient studies allow for a tailored assessment of your value proposition: How are patients or consumers perceiving my product? Are we conveying our messages in the right way? Have we set the right focus? Have we missed something?

Spotlight
Publications

Whitepaper: Digital Health Applications (DiGA) in Portugal

25. June 2024

The whitepaper "Digital Health Applications (DiGA) in Portugal," explores the necessity and current status of implementing a DiGA framework in Portugal, offering expert insights and strategic recommendations for enhancing healthcare through digital solutions.

Webinar | Digital Devices in Pediatrics

24. May 2024

Discover the Transformative Reimbursement Pathways in Pediatric Healthcare through Our Engaging Webinar. Learn about the key aspects, benefits, and processes for achieving reimbursement for innovative healthcare solutions.